This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is(are) drawbacks to the use of methane hydrate as a fuel? a. When melted, ... (Read 77 times)

Hungry!

  • Hero Member
  • *****
  • Posts: 1,071
Which of the following is(are) drawbacks to the use of methane hydrate as a fuel?
 a. When melted, it produces methane, a greenhouse gas.
  b. It is difficult to mine as a solid located at the bottom of the oceans.
  c. It is mixed with water.
  d. All of these are drawbacks associated with methane hydrate.

Question 2

Ethyne, HCCH, is also named ______________.
 Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tkempin

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

d

Answer to Question 2

acetylene




Hungry!

  • Member
  • Posts: 1,071
Reply 2 on: Jul 28, 2018
Great answer, keep it coming :)


covalentbond

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Excellent

 

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library